Variable | Univariate analysis | Multivariate logistic regression | ||||
OR | p Value | 95% CI | OR | p Value | 95% CI | |
Age, years | 1.032 | 0.171 | 0.99 to 1.08 | |||
BMI, kg/m2 | 0.925 | 0.035 | 0.86 to 0.99 | 0.905 | 0.029 | 0.83 to 0.99 |
Lung function | ||||||
FEV1, litres | 0.504 | 0.392 | 0.11 to 2.42 | |||
% predicted FEV1, % | 0.998 | 0.923 | 0.97 to 1.03 | |||
FEV1/FVC, % | 1.0 | 0.998 | 0.96 to 1.04 | |||
PaCO2, mm Hg | 1.049 | <0.0001 | 1.03 to 1.07 | 1.041 | 0.002 | 1.02 to 1.07 |
PaO2, mm Hg | 0.996 | 0.683 | 0.98 to 1.02 | |||
CRP, mg/l | 1.05 | 0.949 | 0.99 to 1.07 | |||
Clinical scores | ||||||
BAP65, increment by 1 | 1.665 | 0.065 | 0.97 to 2.86 | |||
CURB65, increment by 1 | 2.171 | <0.0001 | 1.42 to 3.32 | 1.684 | 0.075 | 0.95 to 2.98 |
Past medical history | ||||||
Cardiovascular disease | 0.701 | 0.504 | 0.25 to 1.99 | |||
Cerebral vascular disease | 1.990 | 0.248 | 0.62 to 6.40 | |||
Malignancy | 0.466 | 0.467 | 0.06 to 3.64 | |||
Biochemical markers of cardiac dysfunction | ||||||
NT-proBNP >220 pmol/l | 9.034 | <0.0001 | 3.11 to 26.25 | 7.455 | 0.004 | 1.92 to 28.90 |
9.241* | 0.001 | 2.58 to 33.05 | ||||
Troponin T >0.03 μg/l | 6.333 | <0.0001 | 2.43 to 16.50 | 2.468 | 0.138 | 0.75 to 8.15 |
5.115† | 0.003 | 1.73 to 15.15 |
Multivariate logistic regression was performed only on risk factors significant in univariate analyses (BMI, pco2, CURB65 score, high NT-proBNP and high troponin T). Results for elevated NT-proBNP and troponin T are presented before and after adjustments for each other. ORs refer to the change in odds of mortality at 30 days associated with an increase in the predictor variables by one of the respective units.
↵* Analyses include all other variables in the multivariate model except elevated troponin T.
↵† Analyses include all other variables in the multivariate model except elevated NT-proBNP.
BMI, body mass index; CRP, C-reactive protein; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; NT-proBNP, N-terminal pro-brain natriuretic peptide.